Maria Elena Hochkoeppler

Maria Elena Hochkoeppler is a seasoned professional in stability and quality control, currently serving as the Senior Manager of Stability, Standards, and Controls Program at Allogene Therapeutics since March 2019. Prior experience includes a tenure as Senior Manager of Stability Commercial QC at Intarcia Therapeutics, Inc. from July 2017 to March 2019, and an extensive role at Novartis from January 2009 to July 2017, where positions ranged from Manager/Compliance and Operations to Senior Scientist and Scientist. Additionally, Maria Elena worked as a Senior Research Associate at Nektar Therapeutics from June 2006 to December 2008. Educationally, Maria Elena holds a Bachelor of Science degree in Biochemistry from California Polytechnic State University-San Luis Obispo.